Latex sublingual immunotherapy: can its safety be predicted?


Buyukozturk S., Gelincik A., Ozseker F., Colakoglu B., Dal M.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol.104, no.4, pp.339-342, 2010 (SCI-Expanded) identifier identifier identifier

Abstract

Background: Complete avoidance sometimes cannot be possible in latex-allergic health care workers. So far, very few double-blind placebo-controlled studies revealed the efficacy of sublingual latex immunotherapy (SLIT) in those patients.